U.S. And Latin America Chronic Wound Care Market Size, Share & Trends Analysis Report By Product (Advanced Wound Dressing, Surgical Wound Care), By Application (Diabetic Foot Ulcers, Pressure Ulcers), By End-use, By Region, And Segment- Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2024-2033

The U.S. and Latin America chronic wound care market size was estimated at USD 6.45 billion in 2023 and is projected to hit around USD 9.66 billion by 2033, growing at a CAGR of 4.12% during the forecast period from 2024 to 2033.

U.S. And Latin America Chronic Wound Care Market Size, 2024 to 2033

Key Takeaways:

  • The U.S. & Latin America chronic wound care market with the highest market share of around 36% in 2023. Also, it is expected to grow at the highest compound annual growth rate (CAGR) of 4.39% from 2024 to 2033.
  • The diabetic foot ulcers segment dominated the U.S. & Latin America chronic wound care market with the largest market revenue share in 2023.
  • The pressure ulcers segment is expected to grow at the highest compound annual growth rate (CAGR) from 2024 to 2033.
  • The hospitals end-use led the market in 2023.
  • The home healthcare segment is expected to grow at the highest compound annual growth rate (CAGR) from 2024 to 2033.

U.S. And Latin America Chronic Wound Care Market Overview

The chronic wound care market in the United States and Latin America is witnessing significant growth and transformation due to a myriad of factors, including the rising prevalence of chronic wounds, advancements in healthcare technologies, and evolving regulatory landscapes. This overview aims to provide a comprehensive understanding of the current state of the market, highlighting key trends, challenges, and opportunities that shape the landscape of chronic wound care in these regions.

U.S. And Latin America Chronic Wound Care Market Growth

The growth of the chronic wound care market in the United States and Latin America is propelled by a confluence of factors. Firstly, the escalating prevalence of chronic wounds, including diabetic ulcers, pressure sores, and venous ulcers, has underscored the urgent need for advanced wound care solutions. As the aging population increases and lifestyle-related conditions become more prevalent, the demand for effective wound management continues to rise. Additionally, technological advancements in wound care, such as the development of innovative dressings, bioactive materials, and smart monitoring devices, contribute significantly to improved patient outcomes, fostering market expansion. The dynamic regulatory landscape, though presenting challenges, also plays a pivotal role by providing a framework for product approvals and ensuring patient safety. Furthermore, the competitive landscape, marked by the presence of key market players investing in research and development, further fuels innovation and market growth. In navigating these growth factors, stakeholders in the U.S. and Latin America chronic wound care market are poised to contribute to the evolution of comprehensive and effective solutions for chronic wound management.

U.S. And Latin America Chronic Wound Care Market Report Scope

Report Attribute Details
Market Size in 2024 USD 6.72 Billion
Market Size by 2033 USD 9.66 Billion
Growth Rate From 2024 to 2033 CAGR of 4.12%
Base Year 2023
Forecast Period 2024 to 2033
Segments Covered Product, Application, End-use, region
Market Analysis (Terms Used) Value (US$ Million/Billion) or (Volume/Units)
Report Coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Key Companies Profiled Smith & Nephew PLC; Mölnlycke Health Care AB; ConvaTec Group PLC; Baxter International; Coloplast Corp.; Medtronic; 3M; Derma Sciences (Integra LifeSciences); Medline Industries, Inc.; Ethicon (Johnson & Johnson); B. Braun SE; Cardinal Health, Inc.; Organogenesis Inc; MIMEDX Group, Inc.

 

U.S. And Latin America Chronic Wound Care Market Dynamics

Drivers

  • Increasing Prevalence of Chronic Wounds: The surge in chronic wounds, including diabetic ulcers, pressure sores, and venous ulcers, serves as a primary driver for the growth of the chronic wound care market in the U.S. and Latin America. The aging population and a rise in lifestyle-related health issues contribute to a higher incidence of chronic wounds, necessitating advanced and effective wound care solutions.
  • Growing Healthcare Infrastructure: The continuous development and improvement of healthcare infrastructure in the U.S. and Latin America provide a conducive environment for the expansion of the chronic wound care market. Access to modern healthcare facilities, specialized wound care centers, and skilled healthcare professionals fosters increased adoption of advanced wound care products and services.

Restraints

  • Limited Reimbursement Policies: One significant restraint in the U.S. and Latin America chronic wound care market is the existence of limited reimbursement policies. Inconsistent or inadequate reimbursement for advanced wound care products and services can hinder patient access and healthcare providers' willingness to adopt these solutions, thereby impeding market growth.
  • Stringent Regulatory Approvals: Stringent regulatory approval processes can slow down the introduction of new and innovative chronic wound care products to the market. Delays in approvals may limit the availability of cutting-edge solutions, affecting the pace at which healthcare providers can offer advanced treatments to patients.

Opportunities

  • Rising Emphasis on Preventive Care: The increasing focus on preventive healthcare presents a significant opportunity in the U.S. and Latin America chronic wound care market. Educational initiatives and proactive interventions to prevent chronic wounds can create a demand for preventive products and services, shaping a paradigm shift towards early intervention and reduced healthcare costs.
  • Advancements in Telehealth and Remote Monitoring: The integration of telehealth and remote monitoring technologies offers a promising opportunity for the chronic wound care market. Remote patient monitoring and telemedicine solutions enhance accessibility to wound care services, especially in remote or underserved areas, promoting timely interventions and personalized care.

Challenges

  • Reimbursement Challenges: In both the U.S. and Latin America, reimbursement challenges pose a significant hurdle for the chronic wound care market. Inconsistent reimbursement policies and the lack of adequate coverage for advanced wound care products and services can limit patient access and hinder healthcare providers' willingness to adopt these solutions.
  • Resistance to Technology Adoption: Resistance to adopting new technologies, particularly among certain healthcare providers and facilities, can impede the widespread integration of advanced chronic wound care solutions. Overcoming traditional practices and convincing stakeholders of the benefits of innovative technologies is a challenge that influences market dynamics.

Segments Insights:

Product Insights

On the basis of product, the market is segmented into advanced wound dressing, surgical wound care, traditional wound care, and wound therapy devices. The advanced wound dressing segment dominated the U.S. & Latin America chronic wound care market with the highest market share of around 36% in 2023. Also, it is expected to grow at the highest compound annual growth rate (CAGR) of 4.39% from 2024 to 2033. Advanced wound dressing is mainly used to treat chronic and nonhealing wounds. Some products of advanced wound dressings are equipped with antimicrobial agents, such as honey & silver, for rapid wound healing and preventing further infections. The limitations of traditional wound dressings have propelled the growth of this market.

U.S. And Latin America Chronic Wound Care Market Share, By Product, 2023 (%)

Moreover, increasing cases of diabetes are also expected to propel segment growth over the forecast period. For instance, in November 2022, according to the Pan American Health Organization (PAHO), about 62 million people live with diabetes in the Americas. Also, the number of people with diabetes in the region is projected to reach 109 million by 2040. These factors are expected to propel the segment growth over the forecast period.

Application Insights

Based on application, the market is segmented into diabetic foot ulcers, pressure ulcers, venous leg ulcers, and others. The diabetic foot ulcers segment dominated the U.S. & Latin America chronic wound care market with the largest market revenue share in 2023. This growth might be attributed to factors such as the increasing incidence of diabetes and diabetic foot ulcers is a major factor driving the segment growth. For instance, according to an NIH report, last updated in August 2023, in the U.S., diabetes is a major cause of non-traumatic amputations. Overall, 5% of patients with diabetes develop foot ulcers, and 1% may lead to amputation. These factors are expected to boost the segment growth over the forecast period.

The pressure ulcers segment is expected to grow at the highest compound annual growth rate (CAGR) from 2024 to 2033. The geriatric population is more vulnerable to pressure ulcers. An increase in the geriatric population may lead to a rise in the number of pressure ulcer patients, which is expected to propel segment growth over the forecast period. For instance, in August 2022, according to NCBI, about 1 to 3 million people in the U.S. develop pressure ulcers every year. Similarly, as per the same source, the incidence of pressure ulcers in hospitalized patients may range from 5% to 15%. These factors are expected to propel the segment growth over the forecast period.

End-Use Insights

The hospitals end-use led the market in 2023. Hospitals use wound care products to treat a variety of wounds, including surgical wounds, burns, pressure ulcers, and diabetic foot ulcers. The demand for advanced wound care products in hospitals is driven by factors such as the growing incidence of chronic wounds, an increase in the number of surgeries, and a rise in the aging population. Surgical wound care dressings and Negative Pressure Wound Therapy (NPWT) are predominantly suitable for hospital use and are not feasible for homecare. This results in the increasing patient pool in hospitals will propel the segment growth over the forecast period.

The home healthcare segment is expected to grow at the highest compound annual growth rate (CAGR) from 2024 to 2033. An increase in the aging population and technological advancement in chronic wound care is expected to drive the segment growth. Furthermore, home healthcare services are often more cost-effective than inpatient care, making them an attractive option for patients, insurers, and healthcare providers. These factors are expected to boost the segment growth over the forecast period.

Recent Developments

  • In April 2023, Convatec Group Plc acquired 30 Technology Limited's anti-infective nitric oxide technology platform, which includes new product assets and research & development verticals.
  • In July 2023, Smith+Nephew introduced the REGENETEN Bioinductive Implant accessible in India. The REGENETEN implant, which has altered how surgeons execute rotator cuff surgery, has been utilized in more than 100,000 procedures.
  • In December 2022, MIMEDX announced the expansion of its wound and surgical products pipeline through an agreement with Turn Therapeutics for in-licensing & distribution.

Key Companies & Market Share Insights

Some of the key players operating in the market include Smith & Nephew PLC; Mölnlycke Health Care AB; ConvaTec Group PLC; Baxter International; Coloplast Corp.; Medtronic; 3M; Derma Sciences (Integra LifeSciences); Medline Industries, Inc.; Ethicon (Johnson & Johnson); B. Braun SE

  • Smith & Nephew is a medical technology company engaged in developing, manufacturing, marketing, and selling services & medical devices. The company provides its services in orthopedics, sports medicine & ENT, and advanced wound care management.
  • Mölnlycke Health Care AB is a medical solutions company. The company manufactures single-use wound and surgical care products. It designs & supplies medical solutions for use in pressure ulcers, infection prevention, and wound treatment, which includes custom procedure trays, antiseptics, dental products, surgical gloves, surgical drapes, orthopedic products, dermatology products, and staff clothing.
  • Organogenesis Inc.; MIMEDX Group, Inc. are some of the emerging market participants in the artificial intelligence market.
  • Organogenesis Holdings Inc. promotes regenerative medicine. Advanced wound care, surgical, and sports medicine are among its product categories. The advanced wound care line of goods is where the corporation makes the most money.
  • MiMedx Group Inc. manufactures and sells products. The human amniotic membrane, birth tissues, human skin, and human bone are used to create regenerative biomaterial products & bioimplants. Its goods are largely focused on the markets for orthopedics, sports medicine, burn care, and wound care.

Key U.S. And Latin America Chronic Wound Care Companies:

  • Smith & Nephew
  • Mölnlycke Health Care AB
  • Convatec Group PLC
  • Baxter International
  • DeRoyal Industries, Inc.
  • Coloplast Corp.
  • 3M
  • Integra LifeSciences
  • Medline Industries, Inc.
  • Johnson & Johnson
  • B. Braun Melsungen AG
  • Cardinal Health, Inc.
  • Organogenesis Inc
  • MIMEDX Group, Inc.

Segments Covered in the Report

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the U.S. And Latin America Chronic Wound Care market.

By Product 

  • Advanced Wound Dressing
  • Surgical Wound Care
  • Traditional Wound Care
  • Wound Therapy Devices

By Application 

  • Diabetic Foot Ulcers
  • Pressure Ulcers
  • Venous Leg Ulcers
  • Other Chronic Wounds

By End-use 

  • Hospitals
  • Specialty Clinics
  • Home Healthcare
  • Others

By Regional 

  • North America
    • U.S.
  • Latin America
    • Brazil
    • Mexico
    • Colombia
    • Panama

Frequently Asked Questions

The U.S. and Latin America chronic wound care market size was estimated at USD 6.45 billion in 2023 and is projected to hit around USD 9.66 billion by 2033

The U.S. chronic wound care market is expected to grow at a compound annual growth rate of 4.12% from 2024 to 2033

Key factors that are driving the market growth include the increasing prevalence of chronic diseases and conditions affecting wound healing capabilities, the introduction of innovative and advanced wound products, the rising geriatric population, the increasing number of ambulatory surgical centers (ASCs) and the steep rise in the number of hospitals & urgent care centers and an increase in hospital admissions.

Some key players operating in the U.S. & LATAM chronic wound care market include Smith & Nephew PLC; Mölnlycke Health Care AB; ConvaTec Group PLC; Baxter International; Coloplast Corp.; Medtronic; 3M; Derma Sciences (Integra LifeSciences); Medline Industries, Inc.; Ethicon (Johnson & Johnson); B. Braun SE; Cardinal Health, Inc.; Organogenesis Inc; MIMEDX Group, Inc.

Chapter 1. Methodology and Scope
                   1.1. Market Segmentation & Scope
                       1.1.1. Product
                       1.1.2. Application
                       1.1.3. End-use
                       1.1.4. Regional scope
                       1.1.5. Estimates and forecast timeline
                   1.2. Research Methodology
                   1.3. Information Procurement
                       1.3.1. Purchased database
                       1.3.2. Nova one advisor’s internal database
                       1.3.3. Secondary sources
                       1.3.4. Primary research
                       1.3.5. Details of primary research
                           1.3.5.1. Data for primary interviews in North America
                           1.3.5.2. Data for primary interviews in Europe
                           1.3.5.3. Data for primary interviews in Asia Pacific
                           1.3.5.4. Data for primary interviews in Latin America
                           1.3.5.5. Data for Primary interviews in MEA
                   1.4. Information or Data Analysis
                       1.4.1. Data analysis models
                   1.5. Market Formulation & Validation
                   1.6. Model Details
                       1.6.1. Commodity flow analysis (Model 1)
                           1.6.1.1. Approach 1: Commodity flow approach
                       1.6.2. Volume price analysis (Model 2)
                           1.6.2.1. Approach 2: Volume price analysis
                   1.7. List of Secondary Sources
                   1.8. List of Primary Sources
                   1.9. Objectives
                       1.9.1. Objective 1
                       1.9.2. Objective 2
Chapter 2. Executive Summary
                   2.1. Market Outlook
                   2.2. Segment Outlook
                       2.2.1. Product outlook
                       2.2.2. Application outlook
                       2.2.3. End-use outlook
                       2.2.4. Regional outlook
                   2.3. Competitive Insights
Chapter 3. U.S. & Latin America Chronic Wound Care Market Variables, Trends & Scope
                   3.1. Market Lineage Outlook
                       3.1.1. Parent market outlook
                       3.1.2. Related/ancillary market outlook
                   3.2. Market Dynamics
                       3.2.1. Market driver analysis
                           3.2.1.1. Increasing prevalence of chronic diseases and conditions affecting wound healing capabilities
                           3.2.1.2. Introduction of innovative and advanced wound products
                           3.2.1.3. Rising geriatric population
                           3.2.1.4. Increasing number of ambulatory surgical centers (ASCs)
                           3.2.1.5. Steep rise in the number of hospitals & urgent care centers and an increase in hospital admissions
                       3.2.2. Market restraint analysis
                           3.2.2.1. Stringent manufacturing policies
                           3.2.2.2. High cost of advanced wound care products and chronic wound treatments
                       3.2.3. Market opportunity analysis
                   3.3. U.S. & Latin America Chronic Wound Care Market Analysis Tools
                       3.3.1. Industry Analysis – Porter’s
                           3.3.1.1. Supplier power
                           3.3.1.2. Buyer power
                           3.3.1.3. Substitution threat
                           3.3.1.4. Threat of new entrant
                           3.3.1.5. Competitive rivalry
                       3.3.2. PESTEL Analysis
                           3.3.2.1. Political landscape
                           3.3.2.2. Technological landscape
                           3.3.2.3. Economic landscape
                       3.3.3. Covid-19 Impact Analysis
Chapter 4. U.S. & Latin America Chronic Wound Care Market: Product Estimates & Trend Analysis
                   4.1. Definitions and Scope
                       4.1.1. Advanced wound dressing
                       4.1.2. Surgical wound care
                       4.1.3. Traditional wound care
                       4.1.4. Wound therapy devices
                   4.2. Product Market Share, 2021 & 2033
                   4.3. Segment Dashboard
                   4.4. U.S. & Latin America Wound Care Market by Product Outlook
                   4.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
                       4.5.1. Advanced wound dressing
                           4.5.1.1. Advanced wound dressing market estimates and forecast 2021 - 2033
                           4.5.1.2. Foam dressings
                               4.5.1.2.1. Foam dressings market estimates and forecast 2021 - 2033
                           4.5.1.3. Hydrocolloid dressings
                               4.5.1.3.1. Hydrocolloid dressings market estimates and forecast 2021 - 2033
                           4.5.1.4. Film dressings
                               4.5.1.4.1. Film dressings market estimates and forecast 2021 - 2033
                           4.5.1.5. Alginate dressings
                               4.5.1.5.1. Alginate dressings market estimates and forecast 2021 - 2033
                           4.5.1.6. Hydrogel dressings
                               4.5.1.6.1. Hydrogel dressings market estimates and forecast 2021 - 2033
                           4.5.1.7. Collagen dressings
                               4.5.1.7.1. Collagen dressings market estimates and forecast 2021 - 2033
                           4.5.1.8. Other advanced dressings
                               4.5.1.8.1. Other advanced dressings market estimates and forecast 2021 - 2033
                       4.5.2. Surgical wound care
                           4.5.2.1. Surgical wound care market estimates and forecast 2021 - 2033
                           4.5.2.2. Sutures & staples
                               4.5.2.2.1. Sutures & staples market estimates and forecast 2021 - 2033
                           4.5.2.3. Tissue adhesives & sealants
                               4.5.2.3.1. Tissue adhesives & sealants market estimates and forecast 2021 - 2033
                           4.5.2.4. Anti-infective dressing
                               4.5.2.4.1. Anti-infective dressing market estimates and forecast 2021 - 2033
                       4.5.3. Traditional wound care
                           4.5.3.1. Traditional wound care market estimates and forecast 2021 - 2033s, (USD Million)
                           4.5.3.2. Medical tapes
                               4.5.3.2.1. Medical tapes market estimates and forecast 2021 - 2033
                           4.5.3.3. Cleansing agents
                               4.5.3.3.1. Cleansing agents market estimates and forecast 2021 - 2033
                           4.5.3.4. Others
                               4.5.3.4.1. Others market estimates and forecast 2021 - 2033
                       4.5.4. Wound therapy devices
                           4.5.4.1. Wound therapy devices market estimates and forecast 2021 - 2033s, (USD Million)
                           4.5.4.2. Negative pressure wound therapy
                               4.5.4.2.1. Negative pressure wound therapy market estimates and forecast 2021 - 2033
                           4.5.4.3. Oxygen and hyperbaric oxygen equipment
                               4.5.4.3.1. Oxygen and hyperbaric oxygen equipment market estimates and forecast 2021 - 2033
                           4.5.4.4. Electric stimulation devices
                               4.5.4.4.1. Electric stimulation devices market estimates and forecast 2021 - 2033
                           4.5.4.5. Pressure relief devices
                               4.5.4.5.1. Pressure relief devices market estimates and forecast 2021 - 2033
                           4.5.4.6. Others
                               4.5.4.6.1. Others market estimates and forecast 2021 - 2033
Chapter 5. U.S. & Latin America Chronic Wound Care Market: Application Estimates & Trend Analysis
                   5.1. Definitions and Scope
                       5.1.1. Diabetic foot ulcers
                       5.1.2. Pressure ulcers
                       5.1.3. Venous leg ulcers
                       5.1.4. Other chronic wounds
                   5.2. Application Market Share, 2021 & 2033
                   5.3. Segment Dashboard
                   5.4. U.S. & Latin America Wound Care Market by Application Outlook
                   5.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
                       5.5.1. Diabetic foot ulcers
                           5.5.1.1. Diabetic foot ulcers market estimates and forecast 2021 - 2033
                       5.5.2. Pressure ulcers
                           5.5.2.1. Pressure ulcers market estimates and forecast 2021 - 2033
                       5.5.3. Venous leg ulcers
                           5.5.3.1. Venous leg ulcers market estimates and forecast 2021 - 2033
                       5.5.4. Other chronic wounds
                           5.5.4.1. Other chronic wounds market estimates and forecast 2021 - 2033
Chapter 6. U.S. & Latin America Chronic Wound Care Devices: End-use Estimates & Trend Analysis
                   6.1. Definitions and Scope
                       6.1.1. Hospitals
                       6.1.2. Specialty clinics
                       6.1.3. Home healthcare
                       6.1.4. Others
                   6.2. End-use Market Share, 2021 & 2033
                   6.3. Segment Dashboard
                   6.4. U.S. & Latin America Wound Care Market by End-use Outlook
                   6.5. Market Size & Forecasts and Trend Analyses, 2021 - 2033 for the following
                       6.5.1. Hospitals
                           6.5.1.1. Hospitals market estimates and forecast 2021 - 2033
                       6.5.2. Specialty clinics
                           6.5.2.1. Specialty clinics market estimates and forecast 2021 - 2033
                       6.5.3. Home healthcare
                           6.5.3.1. Home healthcare market estimates and forecast 2021 - 2033
                       6.5.4. Others
                           6.5.4.1. Others market estimates and forecast 2021 - 2033
Chapter 7. U.S. & Latin America Chronic Wound Care Market: Regional Estimates & Trend Analysis
                   7.1. Regional market share analysis, 2024 & 2033
                   7.2. Regional Market Dashboard
                   7.3. Global Regional Market Snapshot
                   7.4. Regional Market Share and Leading Players, 2023
                       7.4.1. North America
                       7.4.2. Latin America
                   7.5. Market Application, & Forecasts and Trend Analysis, 2021 - 2033
                   7.6. North America
                       7.6.1. Market estimates and forecast, 2021 - 2033
                       7.6.2. U.S.
                           7.6.2.1. Key country dynamics
                           7.6.2.2. Competitive scenario
                           7.6.2.3. Regulatory framework
                           7.6.2.4. Reimbursement scenario
                           7.6.2.5. U.S. market estimates and forecasts, 2021 - 2033
                   7.7. Latin America
                       7.7.1. Brazil
                           7.7.1.1. Key country dynamics
                           7.7.1.2. Competitive scenario
                           7.7.1.3. Regulatory framework
                           7.7.1.4. Reimbursement scenario
                           7.7.1.5. Brazil market estimates and forecasts, 2021 - 2033
                       7.7.2. Mexico
                           7.7.2.1. Key country dynamics
                           7.7.2.2. Competitive scenario
                           7.7.2.3. Regulatory framework
                           7.7.2.4. Reimbursement scenario
                           7.7.2.5. Mexico market estimates and forecasts, 2021 - 2033
                       7.7.3. Colombia
                           7.7.3.1. Key country dynamics
                           7.7.3.2. Competitive scenario
                           7.7.3.3. Regulatory framework
                           7.7.3.4. Reimbursement scenario
                           7.7.3.5. Colombia market estimates and forecasts, 2021 - 2033
                       7.7.4. Panama
                           7.7.4.1. Key country dynamics
                           7.7.4.2. Competitive scenario
                           7.7.4.3. Regulatory framework
                           7.7.4.4. Reimbursement scenario
                           7.7.4.5. Panama market estimates and forecasts, 2021 - 2033
Chapter 8. Competitive Landscape
                   8.1. Recent Developments & Impact Analysis by Key Market Participants
                   8.2. Company Categorization
                   8.3. Company Market Share Analysis
                   8.4. Company Heat Map Analysis
                   8.5. Strategy Mapping
                       8.5.1. Expansion
                       8.5.2. Mergers & Acquisition
                       8.5.3. Partnerships & Collaborations
                       8.5.4. New Product Launches
                       8.5.5. Research And Development
                   8.6. Company Profiles
                       8.6.1. Smith & Nephew PLC
                           8.6.1.1. Company overview
                           8.6.1.2. Financial performance
                           8.6.1.3. Product benchmarking
                           8.6.1.4. Strategic initiatives
                       8.6.2. Mölnlycke Health Care AB
                           8.6.2.1. Company overview
                           8.6.2.2. Financial performance
                           8.6.2.3. Product benchmarking
                           8.6.2.4. Strategic initiatives
                       8.6.3. ConvaTec Group PLC
                           8.6.3.1. Company overview
                           8.6.3.2. Financial performance
                           8.6.3.3. Product benchmarking
                           8.6.3.4. Strategic initiatives
                       8.6.4. Baxter International
                           8.6.4.1. Company overview
                           8.6.4.2. Financial performance
                           8.6.4.3. Product benchmarking
                           8.6.4.4. Strategic initiatives
                       8.6.5. Coloplast Corp.
                           8.6.5.1. Company overview
                           8.6.5.2. Financial performance
                           8.6.5.3. Product benchmarking
                           8.6.5.4. Strategic initiatives
                       8.6.6. Medtronic
                           8.6.6.1. Company overview
                           8.6.6.2. Financial performance
                           8.6.6.3. Product benchmarking
                           8.6.6.4. Strategic initiatives
                       8.6.7. 3M
                           8.6.7.1. Company overview
                           8.6.7.2. Financial performance
                           8.6.7.3. Product benchmarking
                           8.6.7.4. Strategic initiatives
                       8.6.8. Derma Sciences (Integra LifeSciences)
                           8.6.8.1. Company overview
                           8.6.8.2. Financial performance
                           8.6.8.3. Product benchmarking
                           8.6.8.4. Strategic initiatives
                       8.6.9. Medline Industries, Inc.
                           8.6.9.1. Company overview
                           8.6.9.2. Financial performance
                           8.6.9.3. Product benchmarking
                           8.6.9.4. Strategic initiatives
                       8.6.10. 3M
                           8.6.10.1. Company overview
                           8.6.10.2. Financial performance
                           8.6.10.3. Product benchmarking
                           8.6.10.4. Strategic initiatives
                       8.6.11. Ethicon (Johnson & Johnson)
                           8.6.11.1. Company overview
                           8.6.11.2. Financial performance
                           8.6.11.3. Product benchmarking
                           8.6.11.4. Strategic initiatives
                       8.6.12. B. Braun SE
                           8.6.12.1. Company overview
                           8.6.12.2. Financial performance
                           8.6.12.3. Product benchmarking
                           8.6.12.4. Strategic initiatives
                       8.6.13. Cardinal Health, Inc.
                           8.6.13.1. Company overview
                           8.6.13.2. Financial performance
                           8.6.13.3. Product benchmarking
                           8.6.13.4. Strategic initiatives
                       8.6.14. Organogenesis Inc
                           8.6.14.1. Company overview
                           8.6.14.2. Financial performance
                           8.6.14.3. Product benchmarking
                           8.6.14.4. Strategic initiatives
                       8.6.15. MIMEDX Group, Inc.
                           8.6.15.1. Company overview
                           8.6.15.2. Financial performance
                           8.6.15.3. Product benchmarking
                           8.6.15.4. Strategic initiatives

Proceed To Buy

USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers
Ask To Expert